Skip to content

Abaloparatide

Published: July 26, 2026Updated: August 25, 2026

Tymlos (abaloparatide) is a synthetic protein analog used to treat osteoporosis in postmenopausal women and men at high risk for fractures. It is administered as a daily subcutaneous injection and works by stimulating new bone formation, thereby increasing bone mineral density.

Quick summary

Tymlos is an injectable osteoporosis medication that stimulates bone formation to reduce fracture risk in high-risk patients.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

RxNorm
1921077
Generic
Tymlos
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Treatment of osteoporosis in postmenopausal women at high risk for fractures, and to increase bone density in men with osteoporosis at high risk for fractures. High risk is typically defined as patients with a history of osteoporotic fracture or those who have failed or are intolerant to other available osteoporosis therapies.

Abaloparatide is a synthetic analog of parathyroid hormone-related protein (PTHrP). It binds to and activates the parathyroid hormone receptor (PTH1R) on osteoblasts, stimulating bone formation and increasing bone mineral density.

Contraindicated in patients with hypercalcemia, Paget's disease, or history of skeletal malignancies. Carries a boxed warning for potential risk of osteosarcoma based on animal studies; use is generally limited to 2 years. Common side effects include hypercalcemia, dizziness, headache, nausea, and injection site reactions. Requires proper storage (refrigeration) and is administered via daily subcutaneous injection.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy